{"entity":{"type":"insider","cik":"0001318999","url":"/insider/0001318999","json_url":"/insider/0001318999.json","name":"Avalon Ventures VII L P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":13,"first":"2007-08-20","last":"2017-07-28","span_basis":"filed_date"},"name_variants":[{"name":"Avalon Ventures VII L P","source":"filing","n_filings":13,"first_seen":"2007-08-20","last_seen":"2017-07-28"}],"transactions":[{"id":4927258,"accession":"0000899243-17-019280","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-019280","line_url":"/filing/0000899243-17-019280#line-3","is_derivative":false,"issuer_cik":"0001311643","issuer_name":"ANAPTYSBIO INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001311643","owner_cik":null,"owner_name":"Tomlin Stephen Lawrence; AVALON VENTURES VII GP, LLC; Avalon Ventures VII L P; Kinsella Kevin J","owner_display_name":"Tomlin Stephen Lawrence","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37040.0,"shares_display":"37,040","price_per_share":24.35,"price_display":"24.35","price_state":"stated","total_value":901924.0,"total_display":"901,924.00","total_whole":"901,924","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-26","filed_date":"2017-07-28","scope":"insider"},{"id":3646432,"accession":"0001116679-08-000920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001116679-08-000920","line_url":"/filing/0001116679-08-000920#line-1","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2352942.0,"shares_display":"2,352,942","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":2000000.7,"total_display":"2,000,000.70","total_whole":"2,000,001","shares_owned_after":7670442.0,"shares_owned_after_display":"7,670,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-25","filed_date":"2008-03-27","scope":"insider"},{"id":6906495,"accession":"0001116679-07-003017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001116679-07-003017","line_url":"/filing/0001116679-07-003017","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.725,"price_display":"0.72","price_state":"stated","total_value":14500.0,"total_display":"14,500.00","total_whole":"14,500","shares_owned_after":5317500.0,"shares_owned_after_display":"5,317,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-19","filed_date":"2007-11-21","scope":"insider","n_lines":2},{"id":8497027,"accession":"0001116679-07-002482","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001116679-07-002482","line_url":"/filing/0001116679-07-002482","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.6566666666666666,"price_display":"0.66","price_state":"stated","total_value":4925.0,"total_display":"4,925.00","total_whole":"4,925","shares_owned_after":5297500.0,"shares_owned_after_display":"5,297,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-13","filed_date":"2007-09-14","scope":"insider","n_lines":2},{"id":8497015,"accession":"0001116679-07-002482","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001116679-07-002482","line_url":"/filing/0001116679-07-002482","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.5633333333333334,"price_display":"0.56","price_state":"stated","total_value":8450.0,"total_display":"8,450.00","total_whole":"8,450","shares_owned_after":5297500.0,"shares_owned_after_display":"5,297,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-12","filed_date":"2007-09-14","scope":"insider","n_lines":3},{"id":7792630,"accession":"0001116679-07-002427","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001116679-07-002427","line_url":"/filing/0001116679-07-002427","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":0.518,"price_display":"0.52","price_state":"stated","total_value":6475.0,"total_display":"6,475.00","total_whole":"6,475","shares_owned_after":5275000.0,"shares_owned_after_display":"5,275,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-11","filed_date":"2007-09-12","scope":"insider","n_lines":2},{"id":7792627,"accession":"0001116679-07-002427","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001116679-07-002427","line_url":"/filing/0001116679-07-002427","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":13000.0,"total_display":"13,000.00","total_whole":"13,000","shares_owned_after":5275000.0,"shares_owned_after_display":"5,275,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-10","filed_date":"2007-09-12","scope":"insider","n_lines":7},{"id":7017148,"accession":"0001116679-07-002396","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001116679-07-002396","line_url":"/filing/0001116679-07-002396","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.4775,"price_display":"0.48","price_state":"stated","total_value":9550.0,"total_display":"9,550.00","total_whole":"9,550","shares_owned_after":5237500.0,"shares_owned_after_display":"5,237,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-06","filed_date":"2007-09-10","scope":"insider","n_lines":4},{"id":6815581,"accession":"0001116679-07-002379","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001116679-07-002379","line_url":"/filing/0001116679-07-002379","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.475,"price_display":"0.48","price_state":"stated","total_value":9500.0,"total_display":"9,500.00","total_whole":"9,500","shares_owned_after":5217500.0,"shares_owned_after_display":"5,217,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-05","filed_date":"2007-09-06","scope":"insider","n_lines":4},{"id":6815566,"accession":"0001116679-07-002379","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001116679-07-002379","line_url":"/filing/0001116679-07-002379","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":7050.0,"total_display":"7,050.00","total_whole":"7,050","shares_owned_after":5217500.0,"shares_owned_after_display":"5,217,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-04","filed_date":"2007-09-06","scope":"insider","n_lines":3},{"id":7268879,"accession":"0001116679-07-002348","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001116679-07-002348","line_url":"/filing/0001116679-07-002348#line-3","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17500.0,"shares_display":"17,500","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":8750.0,"total_display":"8,750.00","total_whole":"8,750","shares_owned_after":5182500.0,"shares_owned_after_display":"5,182,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-31","filed_date":"2007-09-04","scope":"insider"},{"id":7268878,"accession":"0001116679-07-002348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001116679-07-002348","line_url":"/filing/0001116679-07-002348","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.49333333333333335,"price_display":"0.49","price_state":"stated","total_value":7400.0,"total_display":"7,400.00","total_whole":"7,400","shares_owned_after":5182500.0,"shares_owned_after_display":"5,182,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-09-04","scope":"insider","n_lines":2},{"id":7073085,"accession":"0001116679-07-002309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001116679-07-002309","line_url":"/filing/0001116679-07-002309#line-2","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.48,"price_display":"0.48","price_state":"stated","total_value":4800.0,"total_display":"4,800.00","total_whole":"4,800","shares_owned_after":5150000.0,"shares_owned_after_display":"5,150,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-29","filed_date":"2007-08-30","scope":"insider"},{"id":8368086,"accession":"0001116679-07-002288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001116679-07-002288","line_url":"/filing/0001116679-07-002288#line-1","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.51,"price_display":"0.51","price_state":"stated","total_value":2550.0,"total_display":"2,550.00","total_whole":"2,550","shares_owned_after":5135000.0,"shares_owned_after_display":"5,135,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-24","filed_date":"2007-08-28","scope":"insider"},{"id":8368083,"accession":"0001116679-07-002244","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001116679-07-002244","line_url":"/filing/0001116679-07-002244#line-3","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":7500.0,"total_display":"7,500.00","total_whole":"7,500","shares_owned_after":5130000.0,"shares_owned_after_display":"5,130,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-23","filed_date":"2007-08-24","scope":"insider"},{"id":8368081,"accession":"0001116679-07-002244","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001116679-07-002244","line_url":"/filing/0001116679-07-002244","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.505,"price_display":"0.50","price_state":"stated","total_value":5050.0,"total_display":"5,050.00","total_whole":"5,050","shares_owned_after":5130000.0,"shares_owned_after_display":"5,130,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-22","filed_date":"2007-08-24","scope":"insider","n_lines":2},{"id":7694359,"accession":"0001116679-07-002213","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001116679-07-002213","line_url":"/filing/0001116679-07-002213","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55000.0,"shares_display":"55,000","price_per_share":0.5181818181818182,"price_display":"0.52","price_state":"stated","total_value":28500.0,"total_display":"28,500.00","total_whole":"28,500","shares_owned_after":5105000.0,"shares_owned_after_display":"5,105,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-21","filed_date":"2007-08-22","scope":"insider","n_lines":3},{"id":7694353,"accession":"0001116679-07-002213","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001116679-07-002213","line_url":"/filing/0001116679-07-002213","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.505,"price_display":"0.50","price_state":"stated","total_value":5050.0,"total_display":"5,050.00","total_whole":"5,050","shares_owned_after":5105000.0,"shares_owned_after_display":"5,105,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-20","filed_date":"2007-08-22","scope":"insider","n_lines":2},{"id":7733291,"accession":"0001116679-07-002172","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001116679-07-002172","line_url":"/filing/0001116679-07-002172#line-5","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":2350.0,"total_display":"2,350.00","total_whole":"2,350","shares_owned_after":5040000.0,"shares_owned_after_display":"5,040,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-17","filed_date":"2007-08-20","scope":"insider"},{"id":7733290,"accession":"0001116679-07-002172","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001116679-07-002172","line_url":"/filing/0001116679-07-002172","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":0.4657142857142857,"price_display":"0.47","price_state":"stated","total_value":16300.0,"total_display":"16,300.00","total_whole":"16,300","shares_owned_after":5040000.0,"shares_owned_after_display":"5,040,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-16","filed_date":"2007-08-20","scope":"insider","n_lines":4},{"id":7073083,"accession":"0001116679-07-002309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001116679-07-002309","line_url":"/filing/0001116679-07-002309#line-1","is_derivative":false,"issuer_cik":"0001042420","issuer_name":"AKESIS PHARMACEUTICALS, INC.","issuer_ticker":"AKES.OB","issuer_name_source":null,"issuer_url":"/issuer/0001042420","owner_cik":"0001318999","owner_name":"Avalon Ventures VII L P","owner_display_name":"Avalon Ventures VII L P","owner_url":"/insider/0001318999","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.47,"price_display":"0.47","price_state":"stated","total_value":2350.0,"total_display":"2,350.00","total_whole":"2,350","shares_owned_after":5150000.0,"shares_owned_after_display":"5,150,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-08","filed_date":"2007-08-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":47,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO INC","url":"/issuer/0001370053","role":"Ten percent owner","n_filings":1,"first_seen":"2017-07-28","last_seen":"2017-07-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001042420","name":"AKESIS PHARMACEUTICALS, INC.","url":"/issuer/0001042420","role":"Ten percent owner","n_filings":12,"first_seen":"2007-08-20","last_seen":"2008-03-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001318999","retrieved_at":"2026-08-27T12:31:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}